Survival of Korean Cancer Patients Diagnosed in 1995

Jong Myon Bae; Young Joo Won; Kyu Won Jung; Kyung Ae Suh; Young Ho Yun; Myung Hee Shin; Yoon Ok Ahn; Duk Hee Lee; Hai Rim Shin; Don Hee Ahn; Dae Kyu Oh; Jae Gahb Park

doi:10.4143/crt.2002.34.5.319

Articles

Page Path: HOME > Cancer Res Treat > Volume 34(5); 2002 > Article

Survival of Korean Cancer Patients Diagnosed in 1995: Jong Myon Bae, Young Joo Won, Kyu Won Jung, Kyung Ae Suh, Young Ho Yun, Myung Hee Shin, Yoon Ok Ahn, Duk Hee Lee, Hai Rim Shin, Don Hee Ahn, Dae Kyu Oh, Jae Gahb Park; Cancer Research and Treatment 2002;34(5): 319-325.
DOI: https://doi.org/10.4143/crt.2002.34.5.319
Published online: October 31, 2002

¹Headquarters of Korea Central Cancer Registry, NationalCancer Center, Korea.
²National Medical Center, Korea. park@ncc.re.kr
³Research Institute, National Cancer Center, Korea.
⁴Department of Preventive Medicine, Sungkyunkwan UniversitySchool of Medicine, Korea.
⁵Department of Preventive Medicine, Seoul National UniversityCollege of Medicine, Korea.
⁶Department of Preventive Medicine, College of Medicine,Koshin University, Korea.
⁷Bureau of Health Promotion, Ministry of Health and Welfare,Republic of Korea.

4,326 Views
24 Download
18 Crossref
0 Scopus

Full Article

Download PDF

Abstract

PURPOSE
To produce the nationwide 5-year survival rates of Korean cancer patients by primary cancer site.
MATERIALS AND METHODS
The study subjects were cancer patients diagnosed in 1995, as documented by the Korea Central Cancer Registry (KCCR) Program. This data was collected in 120 (93%) of 129 nationwide intern- and resident-training hospitals and 75 (94%) of the 80 Korean university hospitals. Follow-up was performed by obtaining information upon vital status (i.e., whether living or dead) from the government administered whole population files. Cumulative observed survival rate (OSR) was calculated by using the life table method and the relative survival rate (RSR) was computed using the life-time table for the years 1995, 1997, and 1999.
RESULTS
Of the 55,042 study subjects, the OSR for all Korean cancer patients was 61.4% at 1 year and 38.1% at 5 years. The RSR for all cancers was 62.5% at 1 year and 41.4% at 5 years, and the 5-year RSRs for all cancers in men and women were 32.6% and 53.2%, respectively.
CONCLUSION
This is the first nationwide report upon 5-year cancer survival by primary site in Korea. Men showed a lower survival rate than women in most malignancies. Pancreatic and thyroid cancer had the lowest and highest 5-year survival rates, respectively.

Keywords: Neoplasm;Survival;Population;Korea

Figure & Data

References

Citations

Citations to this article as recorded by

Survival of Stomach Cancer Cases in Khon Kaen, Thailand 2000-2012
Sirinya Nanthanangkul, Krittika Suwanrungruang, Surapon Wiangnon, Supannee Promthet
Asian Pacific Journal of Cancer Prevention.2016; 17(4): 2125. CrossRef
Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy
Seong Hyun Jeong, Jae Ho Jung, Jae Ho Han, Jang Hee Kim, Yong-Won Choi, Hyun Woo Lee, Seok Yun Kang, Yoon Ho Hwang, Mi Sun Ahn, Jin-Hyuk Choi, Young Taek Oh, Mison Chun, Seunghee Kang, Kwang Joo Park, Sung Chul Hwang, Seung Soo Sheen
Lung Cancer.2010; 68(2): 288. CrossRef
Effect of cancer diagnosis on patient employment status: a nationwide longitudinal study in Korea
Jae‐Hyun Park, Jong‐Hyock Park, Sung‐Gyeong Kim
Psycho-Oncology.2009; 18(7): 691. CrossRef
Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer
Seong Hyun Jeong, Jae Ho Jung, Hyun Woo Lee, Seok Yun Kang, Yong Won Choi, Mi Sun Ahn, Yun Ho Hwang, Young Taek Oh, Jin-Hyuk Choi, Seung Soo Sheen, Kwang Joo Park
Journal of Lung Cancer.2009; 8(1): 8. CrossRef
Investigating Effective Combinations of Anti-cancer Drugs and Radiation Therapy for Treating Non-small Cell Lung Cancer with Using Two Cell Lines
In-Jae Oh, Hyun-Ju Cho, Tseden-Ish Manaljav, Yong-Soo Kwon, Kyu-Sik Kim, Sung-Chul Lim, Young-Chul Kim, Sung-Ja Ahn
Journal of Lung Cancer.2009; 8(1): 21. CrossRef
What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea?
Sang Min Park, Sun-Young Kim, Craig C Earle, Seung-Yong Jeong, Young Ho Yun
World Journal of Gastroenterology.2009; 15(25): 3153. CrossRef
Low Expression of Bax Predicts Poor Prognosis in Resected Non-small Cell Lung Cancer Patients with Non-squamous Histology
S. H. Jeong, H.-W. Lee, J. H. Han, S. Y. Kang, J.-H. Choi, Y. M. Jung, H. Choi, Y. T. Oh, K. J. Park, S. C. Hwang, S. S. Sheen, Y. J. Oh, J. H. Kim, H.-Y. Lim
Japanese Journal of Clinical Oncology.2008; 38(10): 661. CrossRef
Comparison of Cancer Survival by Age Group for 1997 and for 2002: Application of Period Analysis using the National Cancer Incidence Database
Seon-Hee Yim, Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Hai-Rim Shin
Journal of Preventive Medicine and Public Health.2008; 41(1): 17. CrossRef
Socio-economic status and the risk of liver cancer mortality: A prospective study in Korean men
S. Joshi, Y.-M. Song, T.-H. Kim, S.-I. Cho
Public Health.2008; 122(11): 1144. CrossRef
Job Loss and Re-Employment of Cancer Patients in Korean Employees: A Nationwide Retrospective Cohort Study
Jae-Hyun Park, Eun-Cheol Park, Jong-Hyock Park, Sung-Gyeong Kim, Sang-Yi Lee
Journal of Clinical Oncology.2008; 26(8): 1302. CrossRef
Cancer Survival in Korea 1993-2002: A Population-Based Study
Kyu-Won Jung, Seon-Hee Yim, Hyun-Joo Kong, Soon-Young Hwang, Young-Joo Won, Jong-Koo Lee, Hai-Rim Shin
Journal of Korean Medical Science.2007; 22(Suppl): S5. CrossRef
Population-based Breast Cancer Statistics in Korea during 1993-2002: Incidence, Mortality, and Survival
Jin-Hee Lee, Seon-Hee Yim, Young-Joo Won, Kyu-Won Jung, Byung Ho Son, Hy-De Lee, Eun-sook Lee, Keun-Young Yoo, Sei Hyun Ahn, Hai-Rim Shin
Journal of Korean Medical Science.2007; 22(Suppl): S11. CrossRef
The Role of Heme Oxygenase-1 in Lung Cancer Cells
Jong-Hoon Jung, Hak-Ryul Kim, Eun-Jung Kim, Ki-Eun Hwang, So-Young Kim, Jung-Hyun Park, Hwi-Jung Kim, Sei-Hoon Yang, Eun-Taik Jeong
Tuberculosis and Respiratory Diseases.2006; 60(3): 304. CrossRef
Feasible economic strategies to improve screening compliance for colorectal cancer in Korea
Sang Min Park
World Journal of Gastroenterology.2005; 11(11): 1587. CrossRef
Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas
Young Hwa Soung, Jong Woo Lee, Su Young Kim, Yong Jik Sung, Won Sang Park, Suk Woo Nam, Sang Ho Kim, Jung Young Lee, Nam Jin Yoo, Sug Hyung Lee
Oncogene.2005; 24(1): 141. CrossRef
Cigarette Smoking, Alcohol Drinking, Hepatitis B, and Risk for Hepatocellular Carcinoma in Korea
S. H. Jee, H. Ohrr, J. W. Sull, J. M. Samet
JNCI Journal of the National Cancer Institute.2004; 96(24): 1851. CrossRef
A Phase II Trial of Docetaxel and Ifosfamide for Patients with Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting
Gyeong-Won Lee, Jung-Hun Kang, Seok-Hyun Kim, Hea Yong Lee, Ho-Cheol Kim, Won-Sup Lee, Jong-Duk Lee, Young-Sil Hwang, Joung-Soon Jang, Jong-Seok Lee
Cancer Research and Treatment.2004; 36(5): 287. CrossRef
Lung Cancer : Overview
Jin Soo Lee
Journal of the Korean Medical Association.2003; 46(1): 7. CrossRef

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Survival of Korean Cancer Patients Diagnosed in 1995

Cancer Res Treat. 2002;34(5):319-325. Published online October 31, 2002

DOI: https://doi.org/10.4143/crt.2002.34.5.319